Skip to main content
Home
FULL MENU Close Menu
Home
Home

Myles Starr

News

Maintenance therapies boost MM survival rates

Author:
Myles Starr
Publish date: February 1, 2023

Interim results in the phase 3 ATLAS trial seemed to buttress the benefits of intensive maintenance therapies for multiple myeloma, post...

  • Read More

News

Systematic review supports preferred drugs for HIV in youths

Author:
Myles Starr
Publish date: December 20, 2022

Findings support the use of dolutegravir an raltegravir as part of WHO-recommended regimens for treating HIV.

  • Read More

News

Exciting advances in HR-positive breast cancer: Top five picks from SABCS

Author:
Myles Starr
Publish date: December 16, 2022

Treatments meet unmet need and address unanswered questions.

  • Read More

News

Key research on TNBC: Top five picks from SABCS

Author:
Myles Starr
Publish date: December 15, 2022

A study on the impact of platinum therapy on long-term TNBC outcomes ranks among the most popular.

  • Read More

News

Pregnancy outcomes on long-acting antiretroviral

Author:
Myles Starr
Publish date: December 14, 2022

“It can be dosed monthly or every 2 months ... This could be a consideration for women who might have problems tolerating oral pills during...

  • Read More

News

Endometrial receptivity testing before IVF seen as unnecessary

Author:
Myles Starr
Publish date: December 13, 2022

Study found that embryo transfer based on the timing of ERT was no better than that based on the standard protocol.

  • Read More

News

Opt-out HIV testing in EDs can help identify undiagnosed cases

Author:
Myles Starr
Publish date: November 23, 2022

On implementation of opt-out testing, the proportion of tests performed increased from 57.9% to 69% in a study.

  • Read More

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close